A method to estimate plutonium content from a limited number of samples of lungs and pulmonary lymph nodes obtained at autopsies of former Mayak Production Association (MPA) workers is described. Historically from one to five samples of lung lobes and one to three respiratory lymph nodes (bronchopulmonary, tracheobronchial and paratracheal) were collected. The samples were used to estimate organ plutonium contents for cases where incomplete sets of samples were obtained, i.e. one to four lung lobes and one to two lymph nodes. This method was developed and validated using individual measurement data from 259 MPA autopsy cases with complete lung samples (five lobes) and three lymph nodes. A good correlation of plutonium content in measurements of two and four lung samples with the content estimate by five lung samples was obtained. The correlations with the individual lymph nodes were less robust than with the lung. The data are used to develop biokinetic, dosimetry and risk models for humans exposed to plutonium.
INTRODUCTION
The Southern Urals Biophysics Institute (SUBI) has monitored plutonium exposures to workers of the Mayak Production Association (MPA) since the early 1950s. The MPA was the first facility in the former Soviet Union for the production of plutonium (1) . The monitoring results show that the internal doses to MPA workers are primarily due to the inhalation of 239 Pucontaining aerosols. Plutonium intakes have been estimated over time using measurements of plutonium content in excreta and applying various biokinetic models. The parameters of these models have been reviewed and revised using data from studies conducted by the Joint Coordinating Committee for Radiation Effects Research (JCCRER), established by the Russian and US governments (2) . Measurements of plutonium in autopsy samples have also been available to help validate and improve International Commission on Radiological Protection (ICRP) models and revise lung clearance model parameters (3, 4) . Lungs are the critical organ for dose-related induction of cancers following inhalation of plutoniumcontaining aerosols (5, 6) . Epidemiological studies carried out under the JCCRER show that lung cancer risk in the MPA workers is the most significant late effect resulting from inhalation of 239 Pu industrial compounds. There is a dose-response relationship between the amount of 239 Pu activity deposited in the lungs and the occurrence of later cancers (7) (8) (9) . Thus the estimation of plutonium content in lungs and other organs is necessary to develop biokinetic models and related risk models (7) (8) (9) . Suslova et al. (10) . described a method to estimate skeletal content of plutonium from a limited set of bone samples obtained at autopsy of MPA workers.
There are a number of factors that determine the deposition patterns of particles in the lung and these include the size, density, shape, charge and surface properties of the particles and the breathing patterns of the affected workers (11, 12) . For example, the ventilation patterns of the lungs are different for the different lobes. During normal respiration, more inspired air will enter the lower lung lobes while at higher inspiratory flow rates, ventilation will become more uniform among the upper and lower lobes (13) . This would result in greater deposition of particles in the lower lobes. Furthermore, the segmented airway tree results in enhanced but non-uniform deposition of particles particularly in the lower lobe (14) . Mucociliary clearance of particles from the lung, a process believed to be somewhat species dependent (15) , also competes with absorption into the blood compartment (11) . From animal experiments on plutonium metabolism it was apparent that after a single or chronic inhalation, the distribution of various plutonium compounds becomes more non-uniform with time after inhalation (16) . Soon after inhalation, plutonium has diffuse lung distribution in animals (17) . With time, due to lung clearance, plutonium redistributes in lung tissue (18) (19) (20) . In late periods after inhalation of different plutonium compounds, the radionuclide concentrations in the superior lobe of the right and left lungs was 1.6 times higher, and in lower lobes about 0.6 times lower compared with the average plutonium concentration in the whole lung (21) . Non-uniformity of plutonium distribution in lungs is indirectly confirmed by epidemiological studies and clinical observations, which show that lung cancer more often develops in upper lobes (22) and radiological changes, are more evident in upper lung lobes for plutonium pneumosclerosis (23) . The non-uniformity of the microdistribution of plutonium in the lungs has been also confirmed using autoradiography studies in both experimental animals (24) and humans (25, 26) . Suslova et al. (27) . noted that for the radiochemical plant workers, plutonium distributes between bronchopulmonary, tracheobronchial and paratracheal lymph nodes with the ratio 0.36:0.36:0.2, respectively in fractions of the total content in all thoracic lymph nodes.
During routine autopsies of MPA workers, samples were taken from all five lobes of the right and left lung in most (about 75%) of the cases. In other cases, particularly those with severe lung pathologies, samples from only one to four lobes were taken. This article describes the method of estimating plutonium content in lung and lymph nodes in cases where limited samples were taken from the lung (1-4 lobes) and lymph nodes (1-2 nodes).
MATERIALS AND METHODS

Mayak workers autopsy lung sampling
Collecting and retaining autopsy samples from MPA workers began in 1955. Currently the SUBI database contains radiochemical information on autopsies conducted from 1955 to 2014. As noted above, the number of tissue samples of lung and thoracic lymph nodes that were collected during autopsies and that were used to measure plutonium varied. For many of the autopsies performed from 1974 to 1994, the protocol was to sample each of the five lung lobes, and if they could be located, collect the bronchopulmonary, tracheobronchial and paratracheal lymph nodes. In total, there were 259 cases where the samples from the five lung lobes and three lymph nodes were available (described in Table 1 ). The mass of lung samples ranged from 30 to 200 g and the lymph nodes from 1 to 6 g.
Anthropometric data (28) that included body mass and height was abstracted for most of the workers from their lifetime medical records maintained at the SUBI archive. The data on MPA worker body mass and height was recorded in medical records for about 70% of the cases.
Radiochemical methods
The methods were described in greater detail earlier (29) (30) (31) (32) . The characteristics of alpha-radiometry and alpha-spectrometry are shown in Table 2 .
The alpha-radiometry method was used for 45 years, from 1955 to 2000. One significant disadvantage of this technique was that it was based on the co-precipitation of plutonium with bismuth Pu (29) . During the period from 1955 to 67, a high-background 40% efficient alpha-radiometer was used. Later, from the 1960's to 2000, a lower background radiometer with 95% efficiency was used. Over time, the chemical methods of sample preparation for measurement were improved that resulted in a reduction of background activity in the samples, A bl , and increased chemical yields. Additionally, the instrumentation was improved resulting in greater measurement sensitivity and accuracy.
Beginning in 2001, alpha-spectrometry was used to measure the plutonium isotopes ( 238 Pu and 239,240 Pu) and 241 Am in autopsy samples using an EC&G ORTEC OCTETE PC spectrometer, which considerably lowered the decision threshold (DT). The DT value, e.g. for 239 ,240 Pu using alphaspectrometry decreased by an order of magnitude (0.005 Bq sample −1 ). The levels of minimum measured activity of plutonium in samples also decreased correspondingly. The lower level of 238, 239, 240 Pu concentration measurement in a lung sample (50 g) with activity corresponding with the DT went from 1.5 mBq g −1 using alpha radiometry to 0.15 mBq g −1 using alpha spectrometry, for lymph nodes (1 g) it went from 65 to 7 mBq g −1 , and the lower level of 239,240 Pu concentration measurement was 0.1 and 5 mBq g −1 , respectively.
Calculation of Pu content in lungs and pulmonary lymph nodes for a complete set of samples
Anatomically lungs are divided into right lung and left lung, which in turn are divided into the lobes: upper, middle and lower lobes in a right lung, and upper and lower lobes in a left lung (33) . In cases with the complete set of all lung lobes (n = 5) and lymph nodes (n = 3), plutonium content in organs Q lung/l.nod for Mayak workers was calculated as a sum of the nuclide content in all lung lobes and three lymph nodes (paratracheal, tracheobronchial and bronchopulmonary):
Where: n = 5 for the cases with lung lobes and n = 3 for lymph nodes. q i -content in i-lobe/i-lymph node. Plutonium content in i-lobe or i-lymph node was calculated as q i = m i c i , by the plutonium concentration measured in a given i-lung lobe/i-lymph node c i , and mass of i-lung lobe/lymph nodes m i .
RESULTS AND DISCUSSION
Definition of masses of lung lobes and individual lymph nodes m i
During the autopsies of the MPA workers, the individual organs were sometimes collected, weighed and the results entered into the records. However, the total organ masses were often not included in the records but when they were, there were considerable ranges in individual organ mass, including lungs. Since the total lung mass was not recorded most of the time, the lung masses were taken for Reference Man (28) . For males the Reference Man with a body mass of 73 kg, a lung mass of 1200 g was used. For Reference Woman a body mass of 60 kg was used with a lung mass of 950 g. The masses of right and left lungs were 0.53 and 0.47 of the whole organ mass, respectively; specifically 636 and 564 g for a Reference Man, and 503 and 447 g for Reference Woman, respectively. The average mass of the tracheobronchial lymph nodes in adults was taken from ICRP-89 (28) and assumed to be 15 g. The plutonium content in whole organs, specifically the lung and thoracic lymph nodes, from a complete set of autopsy samples was estimated by equation (1) as the sum of plutonium content in all of the five lung lobes and three lymph nodes (bronchopulmonary, tracheobronchial and paratracheal). The estimate of content in i-th lung lobe or i-th lymph node required the values of masses of all lung lobes/lymph nodes, m i . There were no data on masses of lung lobes and individual lymph nodes available in literature. The dependency of masses of lung lobes on the whole organ mass is described as a value of the i-th lung lobe mass to the whole organ mass m i /M lung ratio (34) . The values of these ratios for upper, middle and lower right lung lobes were 0.20, 0.08 and 0.25, respectively, and 0.23 and 0.24 for upper and lower left lung lobes, respectively. These values were used to define lung lobe masses for the MPA workers. The masses of lung lobes, as well as lymph nodes, were defined with coefficients designated as µ, considering that lung mass depends on body mass. (28) , the fraction of lymph nodes mass from the whole body mass µ ref is 0.0002 for men and women. There are no available data on ratios of masses of individual lymph nodes relative to the total mass of all respiratory tract lymph nodes, so the calculation assumed equal fractions of lymph nodes mass from the total mass of pulmonary lymph nodes equal 15 g, as 1:1:1, i.e. 5 g for bronchopulmonary, paratracheal and tracheobronchial lymph nodes.
The values of the µ i coefficients from Table 3 were used to define the mass of each i-th lung lobe (and ilymph node), m i , accounting for a Corrected Body Mass (CBM), according to equation (3) .
i i
Corrected body mass
It was found that the estimates of content in i-th lung lobes and in i-th lymph nodes required additional data on the masses of lung lobes/lymph nodes, m i , which are assumed to depend on the mass of whole lung and whole body. ICRP-89 (28) provides weights and heights for Reference Man and Woman: body mass is 73 and 60 kg, respectively, with height 176 and 163 cm, respectively. From the MPA worker records that were available, there is a deviation of average values of about ±15% compared with ICRP values. About 11% of the males and 5% of the females in the MPA cohort have body masses of less than 62 kg for the males and 50 kg for females. There were about 25% of the males over 85 kg and 50% of the females over 70 kg. The distributions of body weights in male and female MPA workers are illustrated in Figure 1a . The distributions of heights in male and female MPA workers are presented in Figure 1b and were similar to those for Reference Man and Woman.
There were noticeable deviations of body mass from the reference values in cases of severe pathology that included cancers and obesity. On the other hand, those workers that were considered relatively 'healthy' from a review of their medical records had essentially insignificant deviations of body mass compared to the reference values. The average body mass for healthy MPA male workers was 75 ± 11 kg and for female workers was 64 ± 13 kg. Some increases of body mass were noted for females with increasing age (Figure 2 ).
According to ICRP-89 (28) and ICRP-23 (35) , the main increase of body mass is caused by increase of body fat with age, particularly for females; but no significant changes in masses of main organs are noted (Figure 3) .
The data on dynamics of body fat accumulation for males and females with age shown in ICRP-89 (28) indicate distinctive differences in fractions of fat deposition over time: 20% fat for a Reference man with body mass of 73 kg and 30% fat for a Reference woman with body mass of 60 kg.
The body fat is physiologically subdivided into two types: 'essential' fat and 'unessential' fat. Essential fat takes part in biochemical processes of a body and comprises approximately 2% of fat-free body mass. Unessential fat is in adipose tissue and is accumulated or used for calorie balance. The main increase of body mass is accounted for through accumulation of the 'unessential' fat. The fraction of plutonium deposition in adipose tissue is not significant compared to other organs. Using the measurement data of concentration in United States Transuranium and Uranium Registries (USTUR) donors' organs one can estimate the fraction of actinides deposited in adipose tissue, which ranges within 0.5-1.5% of the systemic content (36) . ICRP-89 (28) describes a typical relationship of body mass free from the 'unessential' fat, LBM ('lean body mass') with height of a person (L, cm), which was previously used in the model of the 'corrected body mass' CBM to estimate Pu content in skeleton for MPA workers (10) as follows: 
2.50 10 , for females 5 3 2 In the cases where the body mass was more than 15% different from Reference Man body mass, plutonium content in the skeleton was calculated using a corrected body mass that accounted for fat-free body mass (CBM). In this work the CBM was used to define masses of lung lobes (and lymph nodes) while estimating content in i-th lung lobes and i-th lymph nodes, q i , according to equation (1) . For definition of masses of lung lobes and three lymph nodes, m i , the coefficient µ i was considered-a fraction of mass of the i-th lung lobe or i-th lymph node, m i , from CBM, according to equation (3) .
The most robust estimates of plutonium content in lungs can be provided when the entire lung (both right and left) could be measured, as demonstrated from whole body donor studies conducted at the USTUR (31, 37, 38) . However, the autopsy samples for MPA workers were collected from one to five different lobes. Additionally, the individual lung lobes differ not only in the concentration of deposited plutonium, but also by mass. Thus the average concentration derived from measurements from a small number of lung samples, can introduce a large uncertainty into the estimate of total plutonium organ content. In these cases it was important to know the Figure 3 . Dependency of whole body mass and main organs on age for males (a) and females (b), based on data from ICRP 23 and 89 (28, 35) . fraction of plutonium deposited in each lung lobe. For this, the relative distribution of plutonium between lung lobes was characterized by the deposition coefficient K dep,i -fraction of plutonium content in any i-th lung lobe/i-th lymph node of the total plutonium content in the organ. The deposition coefficient K dep,i was estimated by the data on plutonium distribution in lungs in 130 of the 259 MPA autopsy cases where a complete set of all lung lobes and lymph nodes were available (Table 1 ). All cases were selected at random and divided into 130 and 129 cases; 130 cases were used for the coefficient definition, and 129 cases were used for the method verification. The deposition coefficients K dep,i were calculated for five lung lobes and three lymph nodes as a plutonium content in any i-th lung lobe/i-th lymph node, q i (Bq), divided by the total plutonium organ content Q lung/l.nod (Bq):
Plutonium content in an i-th lobe or i-th lymph node was calculated as q i = m i c i , (m i -according to equation (3), Table 3 ).
Effect of transportability on plutonium distribution between lung lobes/lymph nodes
According to exposure history and in vitro studies (39) , it was assumed that the MPA workers were exposed to various plutonium aerosols. The 'transportability' properties of the industrial compounds included three physicochemical forms of plutonium: soluble compounds (nitrate, S = 3.0%), relatively soluble (mixtures of plutonium salts and oxides, S = 1.0%) and insoluble aerosols (dioxide and metal, S = 0.3%). Previous studies (27) show an inverse correlation of plutonium retention in lungs and tracheobronchial lymph nodes with the solubility of industrial aerosols. Thus with increasing solubility (S) there was a decreased fraction of the total body burden of plutonium deposited in the lungs. Additionally, the highest fraction of plutonium deposition in lungs was found in workers with chronic lung diseases; about 30% of total body burden for the workers from the workplaces with aerosols solubility S = 0.3% (plutonium dioxide, metal) and about 3% for the workers from the workplaces with aerosols solubility S = 3.0% (plutonium nitrate) (27) . Table 4 shows the values of plutonium deposition coefficients in lobes of right and left lungs and lymph nodes K dep,i , obtained in 130 cases selected from the 259 MPA worker autopsy cases with a complete set of lungs and related lymph nodes. K dep,i was found by equation (6) .
The inverse correlation of plutonium deposition fraction in whole organ lungs and pulmonary lymph nodes with aerosol solubility was confirmed: high values of K dep,i were obtained for insoluble plutonium compounds (dioxide, metal; S = 0.3%) with a deposition fraction in whole lungs K dep,i = 0.34 and much smaller values were obtained for more soluble compounds (S = 3.0%) of K dep,i = 0.04. There were no significant effects of aerosol solubility on plutonium distribution among lung lobes and among individual lymph nodes, used an Analysis of Variance (Table 4) .
Mean values of K dep,i for lung lobes ranged from 0.08 (middle lobe of the right lung) to 0.25 (upper lobe of the left lung). The lowest value obtained for the middle lobe of the right lung, K dep,i = 0.08. The fractions of plutonium deposition in other lung lobes had a small difference, K dep,i = 0.22-0.25. The relative plutonium distribution between the right and left lungs was practically uniform, the mean value of K dep,i were 0.53 and 0.47, respectively. A trend towards a decrease of plutonium deposition in bronchopulmonary lymph nodes compared to the fractions of deposition in tracheobronchial and paratracheal lymph nodes was observed.
Calculation of plutonium content in lungs and pulmonary lymph nodes for incomplete sets of samples
In the majority of cases 'incomplete' sets of samples were available, specifically one to four samples from lung lobes out of five, and one to two lymph nodes out of three. In these situations the equation used the mean values of the deposition coefficients K dep,i , obtained according to the results of analysis of plutonium distribution between five lung lobes and three lymph nodes in 130 from 259 autopsy cases of the Mayak workers with the complete set of samples from all lung lobes and lymph nodes (Table 4) . To calculate plutonium content in organs in cases with incomplete sets of lung and lymph nodes samples the following equation (7) where: ∑K dep,i -sum of the deposition coefficients of plutonium measured in n-lung lobes (n = 1-4) or in n-lymph nodes (n = 1-2).
Verification of the deposition coefficients K dep,i for lung samples
The coefficients of plutonium deposition were verified for three cases of measurement of plutonium concentration in lung lobes:
(a) plutonium concentration was measured in only one lobe-middle lobe of right lung; (b) concentrations were measured in two lobesupper lobes of left and right lungs; and (c) concentrations were measured in four lobesupper lobes of left and right lungs, middle and lower lobes of right lung.
The verification was based on the comparison of the lung content estimate, calculated by equation (1) for 129 from 259 cases with the complete set of measured samples from five lung lobes, with the lung content calculated by equation (7) for three autopsy cases. The following values of the deposition coefficients K dep,i from Table 4 were used:
(a) for n = 1 K dep,i = 0.08 for the middle lobe of the right lung; (b) for n = 2 ∑ K dep,i = 0.47 for two upper lobes of the right and left lungs; and (c) for n = 4 ∑ K dep,i = 0.75 for four lung lobes excluding the left lung lower lobe.
The correlation was analyzed by comparison of the calculated values by measurements of one to four lung lobes (Q1-Q4) with the actual content, obtained from the measurement results of all five lung lobes (Q5), estimating the value of the ratio calculation/actual Q i /Q5. Good convergence for all calculation variants was obtained, specifically the mean value of the ratio of the calculated estimates to the actual content is one: the mean value of the content ratio Q1/Q5 = 1.09 ± 0.79 (Figure 4a ), Q2/Q5 = 0.98 ± 0.32 (Figure 4b ), Q4/Q5 = 1.01 ± 0.16 ( Figure 4c ). However, as expected, the precision of the estimate of content in organ increased with the number of measured samples: the values of standard deviation decreased from 79% for Q1 to 16% for Q4.
Verification of the deposition coefficients K dep,i for lymph nodes
In cases with incomplete samples of pulmonary lymph nodes (<3) the mean values of the deposition coefficients K dep,i for several lymph nodes (Table 4) were used to calculate content of all of the lymph nodes. The verification was based on the comparison of the content estimate, calculated by equation (1) for 129 from 259 cases with the complete set of measured samples from three lymph nodes, with the content calculated by equation (7) for three types of lymph nodes separately.
The following values of the deposition coefficients K dep,i from Table 4 were used (n = 1):
(1) for bronchopulmonary lymph nodes K dep,i = 0.44; (2) for tracheobronchial lymph nodes K dep,i = 0.29; and (3) for paratracheal lymph nodes K dep,i = 0.27.
The comparison of the calculated values by measurements of several lymph nodes (Q1) with the actual content, obtained from the measurement results of all lymph nodes (Q3) was performed. As seen from Figure 5 , satisfactory convergence for all types of lymph nodes was obtained: the mean value of the content ratio for bronchopulmonary lymph nodes was Q1/Q3 = 1.00 ± 0.43 (Figure 5a ), for tracheobronchial lymph nodes was Q1/Q3 = 0.66 ± 0.48 (Figure 5b ), for paratracheal lymph nodes was Q1/ Q3 = 1.01 ± 0.61 (Figure 5c ). Probably, the large variation was obtained because of the difficulty in accurately separating these regional lymph nodes at autopsy in addition to potential biological variability.
SUMMARY
This article describes the method of estimating plutonium content in lungs and pulmonary lymph nodes used for the MPA workers autopsy cases. The method is applied for the cases with incomplete sets of lung samples (one to four lung lobes, one to two lymph nodes). The method was developed and verified based on the measurement results of 259 autopsy cases of the MPA workers with complete set of samples from five lung lobes and three lymph nodes.
The verification results showed that the accuracy of estimate in lung depends on the number of measured samples. Good correlations were obtained for measurements of samples from four lung lobes: ratio of contents Q4/Q5 = 1.01 ± 0.16, in case of one lung lobe measurement Q1/Q5 = 1.09 ± 0.79. The described method of calculation of plutonium content in the respiratory tract organs based on the results of radiochemical analysis of lung and lymph nodes samples from autopsy of the former MPA workers permits an estimate of organ content with adequate accuracy based on a limited set of samples.
